AAT( Alpha 1 Antitrypsin)

DRUG2 trials

Sponsors

Rabin Medical Center, Universität des Saarlandes

Conditions

Beta Cell PreservationCovid19Type 1 Diabetes

Phase 2

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes

CompletedNCT01661192

Rabin Medical CenterBeta Cell Preservation, Type 1 Diabetes

Start: 2013-01-31End: 2017-01-31Updated: 2017-01-11

Unknown Phase

Alpha-1-Antitrypsin-Deficiency in COVID-19

CompletedNCT04799873

Universität des SaarlandesCovid19

Start: 2020-04-08End: 2020-12-01Updated: 2025-05-25

Related Papers

Long-Term Safety of α-1 Antitrypsin Therapy in Children and Adolescents with Type 1 Diabetes

Immunotherapy2018-09-0117 citations